The Europe sleep apnea devices market is expected to reach US$ 2,804.7 Mn in 2025 from US$ 1,515.5 Mn in 2017. The market is estimated to grow with a CAGR of 8.3% from 2018-2025.
The growth of the sleep apnea devices market is primarily attributed to the increased patient base of sleep apnea and availability of technologically advanced diagnostic & therapeutic devices. However, risks associated with sleep apnea is likely to pose a negative impact on the market growth. On the other hand, adoption of telemedicine is likely to have a positive impact on the growth of the Europe sleep apnea devices market in the coming years.
The obstructive sleep apnea (OSA) syndrome is a highly widespread disorder that affects majorly to men, as compared to women. The OSA is associated with periodic episodes of partial or complete upper airway occlusion during sleep that results in marked sleep disturbance, excessive daytime sleepiness, irritability, morning headache, and other symptoms. The sleep obstructive sleep apnea is strongly associated with a weakened neuropsychological function that reduced the quality of life and social functioning. OSA is a common disorder that affects an estimated 1.5 million adults in the UK. However, up to 85% population is undiagnosed, thus untreated. Undiagnosed OSA is closely associated with serious health problems, including hypertension, diabetes, stroke and heart diseases. Moreover, it increases the risk of road accidents, including fatal collisions.
UK is expected to have high risk of OSA and have good treatment provision in the country. According to the British Lung Foundation, the number of adults with OSA in the UK who are being treated was around 330,000, out of a total population of adults with OSA of around 1.5 million, in 2015. Europe has threefold the amount of people living with sleep apnea as the United States. Therefore, the impact of OAS is significantly higher in the region, which is the major reason for increasing the patient base of OSA in the region.
In 2017, the Polysomnography (PSG) segment held a largest market share of 70.2% of the sleep apnea devices market, by diagnostic devices. The segment is growing due to the combination of diagnosing the EEG and EOG and also the various user friendly functions. Additionally, the polysomnography is growing due it multifunction features, that are friendly and easy to use Furthermore, the oximeters segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.
In 2017, the Positive Airway Pressure (PAP) segment held a largest market share of 52.2% of the sleep apnea devices market, by therapeutic device. This segment is also expected to dominate the market in 2025 as its cost efficient and advanced technology. Furthermore, the oral appliances segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.
Europe sleep apnea devices market, based on end user was segmented into sleep laboratories & hospitals and home healthcare. In 2017, the sleep laboratories & hospitals segment held a largest market share of 88.5% of the sleep apnea devices market, by end user. This segment is also expected to dominate the market in 2025 owing to the technological advancements used for the treatment of angioplasty that depends on the therapeutic approaches. Hospitals also follows the regulations and standards according to the American Academy of Sleep Centres and provides reimbursements to the patients. However, the home healthcare segment is anticipated to witness the fastest growth rate of 9.9% during the forecast period, 2017 to 2025.
Some of the major primary and secondary sources for sleep apnea devices included in the report are, The National Center on Sleep Disorders Research (NCSDR), Department of Assessment of Medical Devices (SED), World Health Organization (WHO), The National Committee for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS) and among others.
The growth of the sleep apnea devices market is primarily attributed to the increased patient base of sleep apnea and availability of technologically advanced diagnostic & therapeutic devices. However, risks associated with sleep apnea is likely to pose a negative impact on the market growth. On the other hand, adoption of telemedicine is likely to have a positive impact on the growth of the Europe sleep apnea devices market in the coming years.
The obstructive sleep apnea (OSA) syndrome is a highly widespread disorder that affects majorly to men, as compared to women. The OSA is associated with periodic episodes of partial or complete upper airway occlusion during sleep that results in marked sleep disturbance, excessive daytime sleepiness, irritability, morning headache, and other symptoms. The sleep obstructive sleep apnea is strongly associated with a weakened neuropsychological function that reduced the quality of life and social functioning. OSA is a common disorder that affects an estimated 1.5 million adults in the UK. However, up to 85% population is undiagnosed, thus untreated. Undiagnosed OSA is closely associated with serious health problems, including hypertension, diabetes, stroke and heart diseases. Moreover, it increases the risk of road accidents, including fatal collisions.
UK is expected to have high risk of OSA and have good treatment provision in the country. According to the British Lung Foundation, the number of adults with OSA in the UK who are being treated was around 330,000, out of a total population of adults with OSA of around 1.5 million, in 2015. Europe has threefold the amount of people living with sleep apnea as the United States. Therefore, the impact of OAS is significantly higher in the region, which is the major reason for increasing the patient base of OSA in the region.
In 2017, the Polysomnography (PSG) segment held a largest market share of 70.2% of the sleep apnea devices market, by diagnostic devices. The segment is growing due to the combination of diagnosing the EEG and EOG and also the various user friendly functions. Additionally, the polysomnography is growing due it multifunction features, that are friendly and easy to use Furthermore, the oximeters segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.
In 2017, the Positive Airway Pressure (PAP) segment held a largest market share of 52.2% of the sleep apnea devices market, by therapeutic device. This segment is also expected to dominate the market in 2025 as its cost efficient and advanced technology. Furthermore, the oral appliances segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.
Europe sleep apnea devices market, based on end user was segmented into sleep laboratories & hospitals and home healthcare. In 2017, the sleep laboratories & hospitals segment held a largest market share of 88.5% of the sleep apnea devices market, by end user. This segment is also expected to dominate the market in 2025 owing to the technological advancements used for the treatment of angioplasty that depends on the therapeutic approaches. Hospitals also follows the regulations and standards according to the American Academy of Sleep Centres and provides reimbursements to the patients. However, the home healthcare segment is anticipated to witness the fastest growth rate of 9.9% during the forecast period, 2017 to 2025.
Some of the major primary and secondary sources for sleep apnea devices included in the report are, The National Center on Sleep Disorders Research (NCSDR), Department of Assessment of Medical Devices (SED), World Health Organization (WHO), The National Committee for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS) and among others.
Table of Contents
1. Introduction1.1 Scope of The Study
1.2 Report Guidance
2. Europe Sleep Apnea Devices Market - Key Takeaways
3. Europe Sleep Apnea Devices - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Sleep Apnea Devices Market - By Diagnostic Devices
3.2.2 Europe Sleep Apnea Devices Market - By Therapeutic Devices
3.2.3 Europe Sleep Apnea Devices Market - By End User
3.2.4 Europe Sleep Apnea Devices Market - By Country
3.3 PEST Analysis
4. Europe Sleep Apnea Devices-Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increased Patient Base of Sleep Apnea Patients
4.1.2 Availability of Technologically Advanced Diagnostic & Therapeutic Devices
4.2 Key Market Restraints
4.2.1 Risks Associated With Sleep Apnea
4.3 Key Market Opportunities
4.3.1 Adoption of Telemedicine
4.4 Future Trends
4.4.1 Merger Activities
4.5 Impact Analysis
5. Sleep Apnea Devices Market - Europe Analysis
5.1 Europe Sleep Apnea Devices Market Revenue Forecasts And Analysis
5.2 Market Positioning/ Market Share
5.3 Performance of Key Players
5.3.1 Resmed
5.3.2 Koninklijke Philips N.V.
5.4 Expert Opinions
6. Europe Sleep Apnea Devices Market - Regulatory Scenario
6.1 Europe
7. Europe Sleep Apnea Devices Market Analysis - By Diagnostic Devices
7.1 Overview
7.2 Europe Sleep Apnea Devices Market, By Diagnostic Devices, 2017 & 2025 (%)
7.3 Europe Sleep Apnea Devices Market Revenue And Forecasts To 2025, By Diagnostic Devices (US$ Mn)
7.4 Europe Sleep Apnea Devices Market Volume And Forecasts To 2025, By Diagnostic Devices (000’units)
7.5 Polysomnography Devices Market
7.5.1 Overview
7.5.2 Europe Polysomnography Devices Market Revenue And Forecasts To 2025 (US$ Mn)
7.6 Respiratory Polygraphs Market
7.6.1 Overview
7.6.2 Europe Respiratory Polygraph Market Revenue And Forecasts To 2025 (US$ Mn)
7.7 Oximeters Market
7.7.1 Overview
7.7.2 Europe Oximeters Market Revenue And Forecasts To 2025 (US$ Mn)
7.8 Actigraphy Systems Market
7.8.1 Overview
7.8.2 Europe Actigraphy Systems Market Revenue And Forecasts To 2025 (US$ Mn)
8. Europe Sleep Apnea Devices Market Analysis - By Therapeutic Devices
8.1 Overview
8.2 Europe Sleep Apnea Devices Market, By Therapeutic Devices, 2017 & 2025 (%)
8.3 Europe Sleep Apnea Devices Market Revenue And Forecasts To 2025, By Therapeutic Devices (US$ Mn)
8.4 Europe Sleep Apnea Devices Market Volume And Forecasts To 2025, By Therapeutic Devices (000’ Units)
8.5 Facial Interfaces Market
8.5.1 Overview
8.5.2 Europe Facial Interfaces Market Revenue And Forecasts To 2025 (US$ Mn)
8.6 Adaptive Servo-Ventilation Instruments (ASV) Market
8.6.1 Overview
8.6.2 Europe Adaptive Servo-Ventilation Instruments (ASV) Market Revenue And Forecasts To 2025 (US$ Mn)
8.7 Positive Airway Pressure (PAP) Devices Market
8.7.1 Overview
8.7.2 Europe Positive Airway Pressure (PAP) Devices Market Revenue And Forecasts To 2025 (US$ Mn)
8.8 Adaptive Oxygen Concentrators Market
8.8.1 Overview
8.8.2 Europe Oxygen Concentrators Market Revenue And Forecasts To 2025 (US$ Mn)
8.9 Airway Clearance Systems Market
8.9.1 Overview
8.9.2 Europe Airway Clearance Systems Market Revenue And Forecasts To 2025 (US$ Mn)
8.10 Oral Appliances Market
8.10.1 Overview
8.10.2 Europe Oral Appliances Market Revenue And Forecasts To 2025 (US$ Mn)
8.11 Accessories Market
8.11.1 Overview
8.11.2 Europe Accessories Market Revenue And Forecasts To 2025 (US$ Mn)9. Europe Sleep Apnea Devices Market Analysis - By End User
9.1 Overview
9.2 Europe Sleep Apnea Devices Market, By End User, 2017 & 2025 (%)
9.3 Europe Sleep Apnea Devices Market Revenue And Forecasts To 2025, By End User (US$ Mn)
9.4 Home Healthcare Market
9.4.1 Overview
9.4.2 Europe Home Healthcare Market Revenue And Forecasts To 2025 (US$ Mn)
9.5 Sleep Laboratories & Hospitals Market
9.5.1 Overview
9.5.2 Europe Sleep Laboratories & Hospitals Market Revenue And Forecasts To 2025 (US$ Mn)
10. Europe Sleep Apnea Devices Market Revenue And Forecasts To 2025
10.1 Overview
10.2 Europe Sleep Apnea Devices Market Revenue And Forecasts To 2025 (US$ Mn)
10.3 Europe Sleep Apnea Devices Market Revenue And Forecasts To 2025, By Diagnostic Devices (US$ Mn)
10.4 Europe Sleep Apnea Devices Market Revenue And Forecasts To 2025, By Therapeutic Devices (US$ Mn)
10.5 Europe Sleep Apnea Devices Market Revenue And Forecasts To 2025, By End User (US$ Mn)
10.6 Europe Sleep Apnea Devices Market Revenue And Forecasts To 2025, By Country (%)
10.7 France Sleep Apnea Devices Market Revenue And Forecasts To 2025 (US$ Mn)
10.8 Germany Sleep Apnea Devices Market Revenue And Forecasts To 2025 (US$ Mn)
10.9 UK Sleep Apnea Devices Market Revenue And Forecasts To 2025 (US$ Mn)
11. Sleep Apnea Devices Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies In The Sleep Apnea Devices Market, 2016-2018
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies In The Sleep Apnea Devices Market, 2016-2018
11.5 Product Launch
11.5.1 Recent Product Launch By Players In The Sleep Apnea Devices Market
11.6 Expansion
11.6.1 Recent Expansion By Players In The Sleep Apnea Devices Market
11.7 Product Development
11.7.1 Recent Product Developments By Players In The Sleep Apnea Devices Market
11.8 Inorganic Growth Strategies
11.8.1 Overview
11.8.2 Agreement
11.8.3 Acquisitions12. Sleep Apnea Devices Market - Key Company Profiles
12.1 Braebon Medical Corporation
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Compumedics Limited
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bmc Medical Co., Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Fisher & Paykel Healthcare Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Resmed Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Somnomed Limited
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Weinmann Emergency Medical Technology Gmbh + Co. Kg
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Devilbiss Healthcare Llc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Koninklijke Philips N.V.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Whole You, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview (Mitsui Chemicals Inc.)
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Publisher
13.2 Glossary of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- RedMed
- Koninklijke Philips N.V.
- Braebon Medical Corporation
- Compumedics Limited
- BMC Medical Co., Ltd.
- Fisher & Paykel Healthcare Limited.
- SomnoMed Limited
- Weinmann Emergency Medical Technology GmbH CO. KG
- Devilbiss Healthcare LLC.
- Whole You, Inc.
